• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Indonesian Patent Policy on Compulsory License and Access to Affordable Medicines.

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Indonesian Patent Policy on Compulsory License and Access to Affordable Medicines.

    Author

    • Nurul Barizah

    Department of International Law, Faculty of Law, UniversitasAirlangga, Surabaya, East Java, Indonesia

,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

The objective of this research article is to analyze the existence of Indonesian Patent Law and policy on providing a compulsory license to use pharmaceutical patents without consent for patent holders to enhance public health in Indonesia. The focus of this research is to examine whether such law and policy adequate to support access to affordable medicines in Indonesia. The type of this research is normative legal research by using statute and conceptual approaches, while legal resources used in this research is primary and secondary legal resources. The statute approach was used in this research to examine all Indonesia legislation, regulations, and policies dealing with this compulsory license on pharmaceutical patents. This research found that normatively, Indonesian Patent Law and Policy dealing with compulsory license is adequate to secure people's access to affordable medicines. Unfortunately, this compulsory license has not been utilized by the Indonesian Government. The Ministry of Human Rights Regulation No. 39 of 2018 concerning Procedures for Granting of Compulsory License to implement the Patent Act of 2016 has issued to apply for such License. This research advises the Government should ensure that procedure and technical guideline to implement this compulsory license is transparent so that it can be understandable by the third party; thus, accessibility and affordability of medicines can be achieved.

Keywords

  • Indonesian Patent Policy
  • Compulsory License
  • Access to Medicines
  • XML
  • PDF 365.72 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 266
    • PDF Download: 313
European Journal of Molecular & Clinical Medicine
Volume 7, Issue 5
November 2020
Page 467-475
Files
  • XML
  • PDF 365.72 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 266
  • PDF Download: 313

APA

Barizah, N. (2020). Indonesian Patent Policy on Compulsory License and Access to Affordable Medicines.. European Journal of Molecular & Clinical Medicine, 7(5), 467-475.

MLA

Nurul Barizah. "Indonesian Patent Policy on Compulsory License and Access to Affordable Medicines.". European Journal of Molecular & Clinical Medicine, 7, 5, 2020, 467-475.

HARVARD

Barizah, N. (2020). 'Indonesian Patent Policy on Compulsory License and Access to Affordable Medicines.', European Journal of Molecular & Clinical Medicine, 7(5), pp. 467-475.

VANCOUVER

Barizah, N. Indonesian Patent Policy on Compulsory License and Access to Affordable Medicines.. European Journal of Molecular & Clinical Medicine, 2020; 7(5): 467-475.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus